Premier Biomedical, Inc. (BIEI)
Premier Biomedical, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Knoxville, PA, US. The stock last traded at $0.00, up 5.26% on the session, giving a market capitalisation of $909,986. On trailing twelve-month figures it carries a trailing P/E of -15.50, a net margin of -127.8%. Its beta of 0.81 implies it has historically moved less than the broad market.
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer’s disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.
Premier Biomedical, Inc. is most often compared with the following Healthcare names: